Ureteral stent having variable hardness

Patent metadata

Field	Value
Publication number	US-9585989-B2
Application number	US-84241007-A
Country	US
Kind code	B2
Filing date	Aug 21, 2007
Priority date	Sep 19, 2006
Publication date	Mar 7, 2017
Grant date	Mar 7, 2017

Abstract

A ureteral stent includes a first material and a second material. The second material is formulated to have a hardness that is greater than a hardness of the first material. The second material is formulated to be soluble in a bodily fluid. The second material is combined with the first material to form a substantially homogeneous combination of the first material and the second material.

First claim

What is claimed is:

1. A non-drug-eluting ureteral stent, comprising:
an elongate portion having an inner surface defining a lumen and an outer surface configured to contact a portion of a body, the elongate portion having a plurality of side ports defined therein, a side port of the plurality of side ports defining an opening from the outer surface to the lumen, the elongate portion having a first retention portion configured to be placed within a bladder of a patient and a second retention portion configured to be placed within a kidney of the patient, the first retention portion being disposed in a first orientation with respect to a longitudinal axis of a medial portion of the elongate portion, the second retention portion being disposed in a second orientation with respect to the longitudinal axis, the second orientation being different than the first orientation, the second retention portion being constructed from a first material and a second material combined with the first material to form a composite of the first material and the second material, the first retention portion being constructed from the first material and being devoid of the second material, a concentration of the second material in the composite of the first material and the second material varying along a length of the elongate portion,
the first material being formulated to be insoluble in a bodily fluid, the second material being formulated to be soluble in the bodily fluid,
the first material having a first hardness, and the second material has a second hardness that is greater than the first hardness,
the first material including a radiopaque material,
the second material, when in contact with the bodily fluid, will dissolve in one hour, such that a hardness of the second retention portion decreases while a size and a shape of the second retention portion remain unchanged, and
a dissolution rate of the second material as a function of a time in contact with the bodily fluid is constant.

2. The non-drug-eluting ureteral stent of claim 1 , wherein a shape of the ureteral stent does not change with dissolution of the second material.

3. The non-drug-eluting ureteral stent of claim 1 , wherein the lumen defines an inner diameter and the outer surface circumscribes the lumen and defines an outer diameter, the inner diameter and the outer diameter remaining constant with a dissolution of the second material.

4. The non-drug-eluting ureteral stent of claim 1 , wherein the first material includes ethylene vinyl acetate having a weight percentage of vinyl acetate ranging from nine percent to forty percent.

5. The non-drug-eluting ureteral stent of claim 1 , wherein a weight percentage of the second material prior to contact with the bodily fluid is between ten percent and eighty percent.

6. The non-drug-eluting ureteral stent of claim 1 , wherein the first material includes a plastic and the second material includes at least one of a synthetic polymer, a plastic, and a hydroxypropylcellulose.

7. A non-drug-eluting medical device, comprising:
an elongate member having a side wall having an inner surface defining a lumen configured to convey a fluid within a body of a patient, the side wall having an outer surface configured to contact a portion of the body, the inner surface defining an inner diameter of the elongate member, the outer surface defining an outer diameter of the elongate member, the elongate member having a plurality of side ports defined therein, a side port of the plurality of side ports defining an opening from the outer surface to the lumen, the elongate member including a distal end portion having a first retention member and being configured to be placed within a kidney of the patient, a proximal end portion having a second retention member and being configured to be placed within a bladder of the patient, and a medial portion disposed between the distal end portion and the proximal end portion, the first retention member being disposed in a first orientation with respect to a longitudinal axis of the medial portion, the second retention member being disposed in a second orientation with respect to the longitudinal axis, the second orientation being different than the first orientation,
the medial portion and the distal end portion including a composite material including a combination of a first material and a second material from the inner surface to the outer surface, a concentration of the second material in the composite material varying along a length of the medial portion and the distal end portion of the elongate member, the proximal end portion including the first material and being devoid of the second material, the second material being formulated to be soluble in a bodily fluid such that dissolution of the second material does not alter the inner and outer diameter of at least one of, and the distal end portion of the elongate member, the second material having a hardness greater than a hardness of the first material,
the medial and distal end portions of the elongate member having a resistance to deformation,
the dissolution of the second material does not alter a shape of the at least one of end portion, the medial portion and the distal end portion, and
the dissolution of the second material causing a decrease in the resistance to deformation of the medial and distal end portions of the elongate member.

8. The non-drug-eluting medical device of claim 7 , wherein the composite material is a melt blend of the first material and the second material.

9. The non-drug-eluting medical device of claim 7 , wherein dissolution of the second material does not alter a cross-sectional area of the at least one of the proximal end portion, the medial portion, and the distal end portion of the elongate member.

10. The non-drug-eluting medical device of claim 7 , wherein the second material includes at least one of a synthetic polymer, a plastic, and a hydroxypropylcellulose.

11. A non-drug-eluting ureteral stent, comprising:
an elongate member having a first retention portion configured to be disposed within a bladder of a patient and a second retention portion configured to be disposed within a kidney of the patient, the first retention portion being disposed in a first orientation with respect to a longitudinal axis of a medial portion of the elongate member, the second retention portion being disposed in a second orientation with respect to the longitudinal axis, the second orientation being different than the first orientation, the elongate member having a plurality of side ports defined therein, a side port of the plurality of side ports defining an opening in the elongate member,
a portion of the elongate member including the second retention portion having a hardness, a size, and a shape, the portion of the elongate member being constructed from a composite material including a combination of a first material formulated to be insoluble in a bodily fluid and a second material formulated to be soluble in the bodily fluid such that upon contact with the bodily fluid the hardness of the portion of the elongate member decreases, while the size and shape of the portion of the elongate member remain unchanged, the second material including a plastic, the first retention portion being constructed of the first material and being devoid of the second material, a concentration of the second material in the composite material varying along a length of the portion of the elongate member,
the first material having a hardness less than a hardness of the second material,
the elongate member having an inner surface defining a lumen configured to convey a fluid within a body of the patient and an outer surface configured t

Assignees

• Deal Travis
• Boston Scient Scimed Inc

Inventors

• Deal Travis

Classifications

• A61L31/041

  Mixtures of macromolecular compounds · CPC title

• A61L31/148 Primary

  Materials at least partially resorbable by the body · CPC title

• A61F2250/0031

  made from both resorbable and non-resorbable prosthetic parts, e.g. adjacent parts · CPC title

• A61F2250/003

  differing in adsorbability or resorbability, i.e. in adsorption or resorption time · CPC title

• A61F2250/0029

  differing in bending or flexure capacity · CPC title